109 related articles for article (PubMed ID: 12888889)
1. A commonly deleted region in ovarian cancer on chromosome 19p13.3, not including the OAZ1 gene.
Yanaihara N; Okamoto A; Matsufuji S
Int J Oncol; 2003 Sep; 23(3):567-75. PubMed ID: 12888889
[TBL] [Abstract][Full Text] [Related]
2. Absence of p51 alteration in human ovarian cancer.
Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
[TBL] [Abstract][Full Text] [Related]
3. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
[TBL] [Abstract][Full Text] [Related]
4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
5. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
6. Infrequent mutation of the human envoplakin gene is closely linked to the tylosis oesophageal cancer locus in sporadic oesophageal squamous cell carcinomas.
Iwaya T; Maesawa C; Kimura T; Ogasawara S; Ikeda K; Kimura Y; Noda Y; Ishida K; Sato N; Saito K; Masuda T
Oncol Rep; 2005 Apr; 13(4):703-7. PubMed ID: 15756445
[TBL] [Abstract][Full Text] [Related]
7. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
8. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
11. Absence of prohibitin gene mutations in human epithelial ovarian tumors.
Cliby W; Sarkar G; Ritland SR; Hartmann L; Podratz KC; Jenkins RB
Gynecol Oncol; 1993 Jul; 50(1):34-7. PubMed ID: 8349162
[TBL] [Abstract][Full Text] [Related]
12. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours.
Wang ZJ; Churchman M; Campbell IG; Xu WH; Yan ZY; McCluggage WG; Foulkes WD; Tomlinson IP
Br J Cancer; 1999 Apr; 80(1-2):70-2. PubMed ID: 10389980
[TBL] [Abstract][Full Text] [Related]
13. FHIT mutations in human primary gastric cancer.
Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC
Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability and frameshift mutations in genes involved in cell cycle progression or apoptosis in ovarian cancer.
Codegoni AM; Bertoni F; Colella G; Caspani G; Grassi L; D'Incalci M; Broggini M
Oncol Res; 1999; 11(7):297-301. PubMed ID: 10757443
[TBL] [Abstract][Full Text] [Related]
15. Marked allelic imbalance on chromosome 5q31 does not explain alpha-catenin expression in epithelial ovarian cancer.
Tuhkanen H; Anttila M; Kosma VM; Puolakka J; Juhola M; Heinonen S; Mannermaa A
Gynecol Oncol; 2004 Aug; 94(2):416-21. PubMed ID: 15297182
[TBL] [Abstract][Full Text] [Related]
16. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
Wiper DW; Zanotti KM; Kennedy AW; Belinson JL; Casey G
Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG
Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923
[TBL] [Abstract][Full Text] [Related]
18. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
Byrski T
Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
[TBL] [Abstract][Full Text] [Related]
19. Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.
Amfo K; Neyns B; Teugels E; Lissens W; Bourgain C; De Sutter P; Vandamme B; Vamos E; De Grève J
Oncogene; 1995 Jul; 11(2):351-8. PubMed ID: 7624149
[TBL] [Abstract][Full Text] [Related]
20. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
